Check out GSA’s New Fellows Forum — Insights on Aging Biology

By CEO James Appleby, BSPharm, MPH

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences — GSA’s top-rated journal as measured by impact factor for 10 years running — has introduced a new feature within its biological sciences pages that will be of interest to all members. The recently launched Fellows Forum enhances the journal’s connections to the GSA membership by providing a platform for fellows in our Biological Sciences Section to share their insights and experience in the field of aging biology.

Science Again Proves Itself a Winning Investment; Share Yours at GSA 2021!

By CEO James Appleby, BSPharm, MPH

GSA is now accepting abstract submissions for this November’s Annual Scientific Meeting! This is your chance to advance the science of aging — and as we take stock of the past year’s upheavals, we find that science was one of few arenas that brought us significant hope.

While the development of new COVID-19 vaccines may be the achievement most people remember from this time, there were critical advances in other important areas, too. National Institutes of Health (NIH) Director, Dr. Francis Collins, recently authored a blog highlighting many of them.

With U.S. Back in WHO, Decade Ahead Looks More Promising

By CEO James Appleby, BSPharm, MPH

The U.S. is back as a full-fledged member of the World Health Organization (WHO) — and that bodes well for bringing a quicker end to the pandemic, the success of the “Decade of Healthy Ageing,” and many other things.

One of the first acts of Joe Biden’s presidency was to retract the withdrawal from WHO enacted by the previous administration. And for the icing on the cake, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci has been tapped to represent the U.S. on the WHO Executive Committee.

Policy Considerations for a Post-COVID Presidency

By CEO James Appleby, BSPharm, MPH

This week will witness the inauguration of our 46th president, Joseph R. Biden Jr. The Biden transition team has been navigating the normally delicate transition process made even more complicated by the COVID-19 pandemic and an uncooperative outgoing administration.

The new administration finds itself preparing policy responses to multiple policy crises on day one. While acute policy responses will fill the initial weeks of the administration, there are longer-term aging issues that will need to be considered in the year ahead.

Fortunately, GSA has assembled the work of some top scholars to help illustrate many of these issues in the latest Public Policy & Aging Report (PP&AR), titled “Policy Considerations for a Post-COVID Presidency.”

First89101113151617Last